[Protein repair therapy in cystic fibrosis]

Annick Clément1, Aline Tamalet, Brigitte Fauroux

  • 1Service de pneumologie pédiatrique Centre de la mucoviscidose Hôpital Armand-Trousseau 75571 Paris. annick.clement@trs.ap-hop-paris.fr

La Revue Du Praticien
|April 1, 2003
PubMed

Insights

Researchers are developing gene therapies and drugs to treat cystic fibrosis by targeting the cystic fibrosis transmembrane conductance regulator (CFTR) protein. Some agents show promise in restoring CFTR function for specific mutations.

Area of Science:

  • Molecular Biology
  • Genetics
  • Pharmacology

Context:

  • Cystic Fibrosis (CF) is a genetic disorder.
  • The cloning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene has advanced understanding of CF.
  • Lung disease progression in CF involves complex mechanisms.

Purpose:

  • To explore therapeutic strategies for cystic fibrosis.
  • To investigate the function and regulation of the CFTR protein.
  • To develop agents that can restore CFTR function.

Summary:

  • Significant progress has been made in understanding CFTR protein function and gene expression regulation.
  • Therapeutic approaches include gene therapy and pharmacological agents.
  • Several agents are being developed to restore function to CFTR mutations.

Impact:

  • Potential for new treatments for cystic fibrosis.
  • Improved understanding of CFTR protein's role in disease.
  • Development of targeted therapies for specific CFTR mutations.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
868
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
520
Mismatch Repair01:36

Mismatch Repair

Overview
43.7K
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
6.5K
Nucleotide Excision Repair01:08

Nucleotide Excision Repair

Overview
40.8K
Overview of DNA Repair02:25

Overview of DNA Repair

In order to be passed through generations, genomic DNA must be undamaged and error-free. However, every day, DNA in a cell undergoes several thousand to a million damaging events by natural causes and external factors. Ionizing radiation such as UV rays, free radicals produced during cellular respiration, and hydrolytic damage from metabolic reactions can alter the structure of DNA. Damages caused include single-base alteration, base dimerization, chain breaks, and cross-linkage.
Chemically...
33.6K